Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
New View Surgical, Inc. logo — Redefining and Simplifying Laparoscopic Surgery

New View Surgical, Inc.

Redefining and Simplifying Laparoscopic Surgery

Founded 2009 United States Boston, United States 5 employees Series B Total: $28.05M Health Care, Health and Wellness +1

General Information

Company Name New View Surgical, Inc.
Founded Year 2009
Location United States Boston, United States
Employees 5
Industries Health Care, Health and Wellness, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with New View Surgical, Inc.. To contact New View Surgical, Inc., visit newviewsurg.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does New View Surgical, Inc. compare?

A PDF of New View Surgical, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting New View Surgical, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About New View Surgical, Inc.

New View Surgical, a Minimally Invasive Surgery (MIS) company, has been redefining and simplifying laparoscopic surgery since its establishment in 2009. The company's primary focus is on enhancing the outcomes of laparoscopic surgical procedures through the commercialization of clinically and economically superior visualization technologies. Their flagship product, VisionPort™, represents a pioneering advancement in MIS visualization, promising to revolutionize the field. This innovative technology aims to simplify minimally invasive procedures, provide surgeons with increased control, enhance safety, and improve technical proficiency. Furthermore, it is projected to substantially reduce the costs associated with visualization systems critical to MIS. New View Surgical recently secured a substantial $12.10M Series B investment on 21 November 2022, indicating strong investor confidence in the company's vision and potential. This substantial investment is set to fuel further development and commercialization efforts, positioning the company for significant growth in the Health Care sector. With its headquarters in the United States, New View Surgical is well-positioned to make a notable impact in the field of MIS and advance the standard of care in laparoscopic surgery.

Business keywords: Minimally Invasive Surgery, Laparoscopic Surgery, Medical Device, Surgical Imaging, Visualization Technology, Healthcare Innovation, Surgical Access System, Medical Technology, Innovation, Surgical Equipment, Medical Innovation

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $12.10M -
21 Nov 2022
Non Equity Assistance Undisclosed 1
MedTech Innovator
MedTech Innovator
07 Jun 2022
Series B $9.00M 8
New York Angels Charleston Angel Partners IAG Capital Partners
New York Angels, Charleston Angel Partners +6
02 Nov 2021
Venture Round $2.07M 1
Keiretsu Capital
Keiretsu Capital
06 Apr 2021
Series A $2.10M 7
Tech Coast Angels New York Angels Ariel Southeast Angel Partners
Tech Coast Angels, New York Angels +5
17 Jun 2019
Series A Undisclosed 1
Keiretsu Capital
Keiretsu Capital
16 Apr 2018
Series A $2.54M 4
New York Angels Ariel Southeast Angel Partners
New York Angels, Ariel Southeast Angel Partners +2
01 Mar 2017
Seed Round $245.00K -
15 Feb 2017
Non Equity Assistance Undisclosed 1
MassChallenge
MassChallenge
01 Jan 2016

New View Surgical, Inc. Alternatives & Competitors

View All Alternatives
New View Surgical, Inc. vs
Caira Surgical
Caira Surgical United States

Engineering the future of navigated and robotic orthopedic surgery.

Seed
9 employees
Health Care, Medical Devices
New View Surgical, Inc. vs
MAKO Surgical Corp.
MAKO Surgical Corp. United States

MAKO Surgical Corp. is a medical device company that markets its advanced robotic solution and impla...

Post-IPO Debt
160 employees
Biotechnology, Health Care
New View Surgical, Inc. vs
Novare Surgical Systems
Novare Surgical Systems

Based in Cupertino, California and founded in 1999, Novare develops, manufactures and markets device...

Series D
6 employees
Health Care, Manufacturing
Also compare with: New View Surgical, Inc. vs Viseon Inc. Viseon Inc. View all alternatives

FAQ About New View Surgical, Inc.

Redefining and Simplifying Laparoscopic Surgery
New View Surgical, Inc. was founded in 2009.
New View Surgical, Inc. is headquartered in Boston, United States.
New View Surgical, Inc. operates in Health Care, Health and Wellness and Medical Devices. Its work centres on Minimally Invasive Surgery, Laparoscopic Surgery, Medical Device and Surgical Imaging.
New View Surgical, Inc. has approximately 5 employees.
New View Surgical, Inc. has completed 9 funding rounds, raising a total of $28.05M. The latest funding stage is Series B.
Top alternatives and competitors to New View Surgical, Inc. include Caira Surgical, MAKO Surgical Corp., Novare Surgical Systems, W.O.M. WORLD OF MEDICINE GmbH, Conkin Surgical Instruments Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
New View Surgical, Inc. and Caira Surgical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for New View Surgical, Inc., https://bouncewatch.com/company/new-view-surgical, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout